Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation
Language English Country Netherlands Media print-electronic
Document type Journal Article
PubMed
27231122
DOI
10.1016/j.ijpharm.2016.05.041
PII: S0378-5173(16)30420-3
Knihovny.cz E-resources
- Keywords
- Arabinogalactan, Asialoglycoprotein receptor, Cholesterol, Hepatocellular carcinoma, Liposomes, Simulations, Targeting,
- MeSH
- Asialoglycoprotein Receptor metabolism MeSH
- Hep G2 Cells MeSH
- Cholesterol chemistry MeSH
- Doxorubicin administration & dosage chemistry metabolism MeSH
- Chemistry, Pharmaceutical methods MeSH
- Galactans chemistry MeSH
- Carcinoma, Hepatocellular drug therapy metabolism MeSH
- Liver drug effects metabolism MeSH
- Drug Delivery Systems methods MeSH
- Humans MeSH
- Liposomes chemistry MeSH
- Cell Line, Tumor MeSH
- Liver Neoplasms drug therapy metabolism MeSH
- Polyethylene Glycols chemistry MeSH
- Antineoplastic Agents administration & dosage chemistry metabolism MeSH
- Tissue Distribution MeSH
- Particle Size MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- arabinogalactan MeSH Browser
- Asialoglycoprotein Receptor MeSH
- Cholesterol MeSH
- Doxorubicin MeSH
- Galactans MeSH
- Liposomes MeSH
- Polyethylene Glycols MeSH
- Antineoplastic Agents MeSH
We have developed active targeting liposomes to deliver anticancer agents to ASGPR which will contribute to effective treatment of hepatocellular carcinoma. Active targeting is achieved through polymeric ligands on the liposome surface. The liposomes were prepared using reverse phase evaporation method and doxorubicin hydrocholoride, a model drug, was loaded using the ammonium sulphate gradient method. Liposomes loaded with DOX were found to have a particle size of 200nm with more than 90% entrapment efficiency. Systems were observed to release the drug in a sustained manner in acidic pH in vitro. Liposomes containing targeting ligands possessed greater and selective toxicity to ASGPR positive HepG2 cell lines due to specific ligand receptor interaction. Bio-distribution studies revealed that liposomes were concentrated in the liver even after 3h of administration, thus providing conclusive evidence of targeting potential for formulated nanosystems. Tumor regression studies indicated greater tumor suppression with targeted liposomes thereby establishing superiority of the liposomal system. In this work, we used a novel methodology to guide the determination of the optimal composition of the targeting liposomes: molecular dynamics (MD) simulation that aided our understanding of the behaviour of the ligand within the bilayer. This can be seen as a demonstration of the utility of this methodology as a rational design tool for active targeting liposome formulation.
Bombay College of Pharmacy University of Mumbai Mumbai 400098 India
Department of Physics Tampere University of Technology PO Box 692 FI 33101 Tampere Finland
References provided by Crossref.org
Tail-Oxidized Cholesterol Enhances Membrane Permeability for Small Solutes